
Industry Watch
In our first issue of Industry Watch for 2021, we’re bringing our readers insights from a founding member of the Human Genome Project, looking at…
In our first issue of Industry Watch for 2021, we’re bringing our readers insights from a founding member of the Human Genome Project, looking at…
Emily Whitehead was born on May 2nd of 2005, a perfectly healthy baby. When she reached five, her parents noticed bruising on her legs, bleeding…
Children and young adults across the globe are largely underrepresented in clinical research. While legal actions such as the Research to Accelerate…
In the first week of November, Industry Watch brings you news of strategies to improve cancer screening via novel multi-cancer early detection (MCED)…
A substantial change to the drug development landscape is currently underway. Regulatory authorities are starting to acknowledge pediatrics as one of…
Welcome to the third edition of the Center for Pediatric Clinical Development (CPCD) newsletter. This quarterly publication will keep you informed on…
This whitepaper offers a high-level orientation around the key barriers to readiness and critical success factors for companies navigating the…
Now that the RACE for Children Act has come into effect, the drug development industry and patients and their families are optimistic—more drugs will…
A Phase II, randomized, double-blind, placebo-controlled, 2-part study to evaluate the safety, tolerability, pharmacokinetics, clinical response, and…
PRA has partnered with The Leukemia and Lymphoma Society (LLS) on a global precision medicine clinical trial for children with relapsed acute…